Medical noticeFor research and educational purposes only. Not medical advice. Consult a licensed physician before using any peptide or compound.

Best peptides for recovery

Recovery peptides are among the most researched in the biohacking community, but nearly all current evidence comes from animal models. The compounds below appear most frequently in preclinical tissue-repair research and community experience reports. No peptide on this list has completed a human clinical trial confirming recovery benefits; claims are based on mechanism and animal data.

  1. 1

    BPC-157

    Tier 3–4 — Preclinical

    BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid pentadecapeptide derived from a gastric protective protein. It has the broadest preclinical evidence base of any recovery peptide — animal studies across tendon, muscle, bone, gut, and nerve tissue showing tissue regeneration effects via NO-pathway activation and VEGF upregulation. Human evidence is limited to a single safety pilot with n=2.

    Full BPC-157 profile →
  2. 2

    TB-500

    Tier 3 — Preclinical

    TB-500 is a synthetic fragment of thymosin beta-4, an endogenous protein involved in actin sequestration and cytoskeletal remodeling. Animal models show cardiac tissue repair and angiogenesis effects. Frequently co-administered with BPC-157 in community protocols due to their proposed complementary mechanisms. No human clinical trials have been published.

    Full TB-500 profile →
  3. 3

    GHK-Cu

    Tier 3–4 — Preclinical

    GHK-Cu is a naturally occurring tripeptide-copper complex found in human plasma. Cell culture and animal studies show wound healing, collagen synthesis stimulation, and anti-inflammatory effects via VEGF upregulation and matrix metalloproteinase modulation. Also used topically in cosmetic formulations, where it has the most accessible human-use data of the compounds on this list.

    Full GHK-Cu profile →
  4. 4

    KPV

    Tier 3–4 — Preclinical

    KPV (Lys-Pro-Val) is a tripeptide derived from the C-terminal sequence of alpha-MSH. Animal models of inflammatory bowel disease show gut-protective and anti-inflammatory effects via MC1R signaling in gut epithelium. Its recovery application is specifically inflammation-mediated; it is not a general tissue-repair compound. No human clinical trials have been published.

    Full KPV profile →

All compounds on this list are classified as research chemicals — not approved for human use. Evidence tiers reflect our research quality classification. Read more at our methodology page.

How we evaluate evidence →